bazedoxifene has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komm, BS; Mirkin, S; Thompson, JR | 1 |
| Arnal, JF; Gourdy, P; Trémollières, F; Valera, MC | 1 |
2 review(s) available for bazedoxifene and Coronary Disease
| Article | Year |
|---|---|
Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials.
Topics: Coronary Disease; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Indoles; Postmenopause; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Stroke; Venous Thromboembolism | 2015 |
From the Women's Health Initiative to the combination of estrogen and selective estrogen receptor modulators to avoid progestin addition.
Topics: Breast Neoplasms; Coronary Disease; Estrogen Receptor alpha; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Menopause; Progestins; Selective Estrogen Receptor Modulators; Venous Thromboembolism; Women's Health | 2015 |